Alan Colman

Summary

Country: Singapore

Publications

  1. ncbi Induced pluripotent stem cells and human disease
    Alan Colman
    Wolfson Centre for Age-Related Disease, King's College London, Guy's Campus, London, UK
    Cell Stem Cell 3:236-7. 2008
  2. ncbi Induced pluripotent stem cells and the stability of the differentiated state
    Alan Colman
    Institute of Medical Biology, Immunos, Singapore
    EMBO Rep 10:714-21. 2009
  3. ncbi Pluripotent stem cells and disease modeling
    Alan Colman
    Institute of Medical Biology, Singapore, Singapore
    Cell Stem Cell 5:244-7. 2009
  4. ncbi Stem cell research in Singapore
    Alan Colman
    Singapore Stem Cell Consortium, A STAR Institute of Medical Biology, Singapore 138648
    Cell 132:519-21. 2008
  5. ncbi Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells
    Xiu Qin Xu
    ES Cell International Pte Ltd, 60 Biopolis St 01 03 Genome, Singapore 138672, Republic of Singapore
    Differentiation 76:958-70. 2008
  6. ncbi Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts
    Wangde Dai
    The Heart Institute, Good Samaritan Hospital, University of Southern California, 1225 Wilshire Boulevard, Los Angeles, CA 90017 2395, USA
    J Mol Cell Cardiol 43:504-16. 2007
  7. ncbi ES Cell International & regenerative medicine
    Alan Colman
    ES Cell International, Helios, Singapore
    Regen Med 1:287-91. 2006
  8. ncbi The generation of six clinical-grade human embryonic stem cell lines
    Jeremy Micah Crook
    Cell Stem Cell 1:490-4. 2007
  9. ncbi Cell therapy and the safety of embryonic stem cell-derived grafts
    Hannes Hentze
    ES Cell International, 11 Biopolis Way, 05 06 Helios Building, 138667 Singapore, Republic of Singapore
    Trends Biotechnol 25:24-32. 2007
  10. ncbi Repressed by a NuRD
    Jeremy M Crook
    Nat Cell Biol 8:212-4. 2006

Collaborators

  • Christine Mummery
  • Robert Zweigerdt
  • Xiu Qin Xu
  • Hannes Hentze
  • Wangde Dai
  • Jeremy Micah Crook
  • Jeremy M Crook
  • Teija Tuulikki Peura
  • Sharon L Hale
  • Martin Pera
  • Florence Chua
  • Lucy Kravets
  • Jeremy James Buzzard
  • Ralph E Graichen
  • Norris Ray Dunn
  • Gregory L Kay
  • Bruce P Davidson
  • Aarne J Jyrala
  • Alan Upshall
  • Ralph Graichen
  • Loren J Field
  • Robert A Kloner
  • Michael Rubart
  • Alexis Gina Bosman
  • Rachel Horne
  • Sean Reuter
  • N Ray Dunn

Detail Information

Publications10

  1. ncbi Induced pluripotent stem cells and human disease
    Alan Colman
    Wolfson Centre for Age-Related Disease, King's College London, Guy's Campus, London, UK
    Cell Stem Cell 3:236-7. 2008
  2. ncbi Induced pluripotent stem cells and the stability of the differentiated state
    Alan Colman
    Institute of Medical Biology, Immunos, Singapore
    EMBO Rep 10:714-21. 2009
    ..Here, we highlight the recent progress, and the implications of this work for our understanding of the relationship between the pluripotent and more differentiated cell states...
  3. ncbi Pluripotent stem cells and disease modeling
    Alan Colman
    Institute of Medical Biology, Singapore, Singapore
    Cell Stem Cell 5:244-7. 2009
    ..hESCs and hiPSCs carrying genetic defects can now be produced to model diseases in vitro. We suggest several guiding principles to help ensure an optimal fit between technology and disease...
  4. ncbi Stem cell research in Singapore
    Alan Colman
    Singapore Stem Cell Consortium, A STAR Institute of Medical Biology, Singapore 138648
    Cell 132:519-21. 2008
    ..Singapore is investing heavily in stem cell research. This investment is part of an ambitious biomedical science initiative designed to enhance its thriving economy...
  5. ncbi Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells
    Xiu Qin Xu
    ES Cell International Pte Ltd, 60 Biopolis St 01 03 Genome, Singapore 138672, Republic of Singapore
    Differentiation 76:958-70. 2008
    ..This study represents a significant step toward developing scalable production for cardiomyocytes from hESC using clinically compliant reagents compatible with Good Manufacturing Practice...
  6. ncbi Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts
    Wangde Dai
    The Heart Institute, Good Samaritan Hospital, University of Southern California, 1225 Wilshire Boulevard, Los Angeles, CA 90017 2395, USA
    J Mol Cell Cardiol 43:504-16. 2007
    ..However, hESC-derived cells did not escape immune surveillance in the xenograft setting in that they elicited a rejection phenomenon in immune competent rats...
  7. ncbi ES Cell International & regenerative medicine
    Alan Colman
    ES Cell International, Helios, Singapore
    Regen Med 1:287-91. 2006
    ..However with demographic changes towards an aging population in the richer countries, leading to growing demands of ways to combat degenerative disease, science would be remiss not to explore every potential medical solution...
  8. ncbi The generation of six clinical-grade human embryonic stem cell lines
    Jeremy Micah Crook
    Cell Stem Cell 1:490-4. 2007
  9. ncbi Cell therapy and the safety of embryonic stem cell-derived grafts
    Hannes Hentze
    ES Cell International, 11 Biopolis Way, 05 06 Helios Building, 138667 Singapore, Republic of Singapore
    Trends Biotechnol 25:24-32. 2007
    ..It is this final safety issue that will form the focus of this review...
  10. ncbi Repressed by a NuRD
    Jeremy M Crook
    Nat Cell Biol 8:212-4. 2006